Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 21, 2007
Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cellsSaswati Hazra, Steven M DubinettThe Journal of Biological Chemistry|November 13, 2004
Adipogenic transcriptional regulation of hepatic stellate cellsHongyun She, Shigang Xiong, Saswati Hazra, et al.Comparative Hepatology|February 13, 2004
PPAR Gamma and Hepatic Stellate CellsSaswati Hazra, Takeo Miyahara, Richard A Rippe, et al.Journal of Gastroenterology and Hepatology|April 11, 2008
Fat paradox of steatohepatitisHidekazu Tsukamoto, Hongyun She, Saswati Hazra, et al.Journal of Gastroenterology and Hepatology|September 9, 2006
Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiationHidekazu Tsukamoto, Hongyun She, Saswati Hazra, et al.PPAR Research|September 5, 2008
The Role of PPARgamma in the Cyclooxygenase Pathway in Lung CancerSaswati Hazra, Katherine A Peebles, Sherven Sharma, et al.Translational Oncology|July 11, 2021
AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenarioAkanksha Farswan, Anubha Gupta, Ritu Gupta, et al.The Journal of Biological Chemistry|January 2, 2004
Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cellsSaswati Hazra, Shigang Xiong, Jiaohong Wang, et al.Molecular Pharmacology|April 7, 2007
Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenaseSaswati Hazra, Raj K Batra, Hsin H Tai, et al.Future Oncology (London, England)|June 4, 2020
Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study designRobin Kate Kelley, Jennifer W Oliver, Saswati Hazra, et al.Pageof 2